Viz.ai, Inc is emerging as the leader in applied artificial intelligence in healthcare. Our mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care. Our flagship product, Viz LVO, leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/18/18 | $21,000,000 | Series A | ||
| 10/24/19 | $50,000,000 | Series B |
CRV Greenoaks Capital Management  GV Kleiner Perkins Caufield and Byers Threshold Ventures | undisclosed |
| 03/17/21 | $71,000,000 | Series C |
CRV Greenoaks Capital Management Innovation Endeavors Insight Partners Kleiner Perkins Caufield and Byers Scale Venture Partners Susa Ventures Threshold Ventures | undisclosed |
| 04/07/22 | $100,000,000 | Series D |
CRV GV Insight Partners Kleiner Perkins Caufield and Byers Scale Venture Partners Sozo Ventures Susa Ventures Threshold Ventures Tiger Global Management | $1,200,000,000 |
| 03/22/23 | $40,000,000 | Growth |
CIBC | undisclosed |
